Search
for
Sort by
Research 61–90 of 1000+
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- BRIDGING THE GAP IN ACNE MANAGEMENT: A NARRATIVE REVIEW OF CURRENT THERAPIES AND THE EMERGENCE OF CLASCOTERONE
- SRD5A2 and emerging therapies in androgen-driven disorders
- Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
- Polycystic Ovary Syndrome-Associated Acne: The Interplay of Hyperandrogenism, Insulin Resistance, and Therapeutic Strategies
- Management of Hirsutism and Acne in Women with Polycystic Ovary Syndrome: A Narrative Review of Current Evidence and Emerging Therapies
- DIAGNOSTIC AND THERAPEUTIC UTILITY OF GONADOTROPHIN-RELEASING HORMONE AGONIST IN POSTMENOPAUSAL HYPERANDROGENISM OF OVARIAN ORIGIN
- Ciclosporin-Induced Generalised Hypertrichosis in a Transgender Woman Receiving Testosterone Blockers
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Hormonal Therapy for Acne
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Androgens’ Effects across the Lifespan in Men and Animal Models
- Alopecia: managing the basics
- 11 Treatment of hirsutism and acne with cyproterone acetate
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Hormonal Therapies in Cosmetic Dermatology: Mechanisms, Clinical Applications, and Future Perspectives
- Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety
- Endocrine Regulation of Hair Growth and Loss: Current Evidence and Clinical Implications
- Hirsutism due to polycystic ovarian syndrome: An integrative review of pathophysiology and management
- Kutane Androgenisierung - Effluvium, Hirsutismus, Akne
- Skin Barrier Dysfunction in Acne Vulgaris: Pathogenesis and Therapeutic Approaches
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Endocrine evaluation of hirsutism
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist